Interaction of angiotensin receptor type 1 blockers with ATP-binding cassette transporters
ATP-binding cassette (ABC)-transporters, such as P-glycoprotein (P-gp/ABCB1), multidrug resistance-associated proteins (MRPs/ABCCs) and breast cancer resistance protein (BCRP/ABCG2) transport numerous drugs thus regulating their absorption, distribution and excretion. Angiotensin receptor type 1 blo...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
10 March 2010
|
| In: |
Biopharmaceutics & drug disposition
Year: 2010, Volume: 31, Issue: 2/3, Pages: 150-161 |
| ISSN: | 1099-081X |
| DOI: | 10.1002/bdd.699 |
| Online Access: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1002/bdd.699 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/bdd.699 
|
| Author Notes: | J. Weiss, A. Sauer, N. Divac, M. Herzog, E. Schwedhelm, R.H. Böger, W.E. Haefeli, and R.A. Benndorf |
| Summary: | ATP-binding cassette (ABC)-transporters, such as P-glycoprotein (P-gp/ABCB1), multidrug resistance-associated proteins (MRPs/ABCCs) and breast cancer resistance protein (BCRP/ABCG2) transport numerous drugs thus regulating their absorption, distribution and excretion. Angiotensin receptor type 1 blockers (ARBs), used to treat hypertension and heart failure, are commonly administered in combination therapy. However, their interaction potential is not well studied and their effect on ABC-transporters remains elusive. The study therefore aimed to elucidate the effect of various ARBs (telmisartan, candesartan, candesartan-cilexetil, irbesartan, losartan, olmesartan, olmesartan-medoxomil, eprosartan) on ABC-transporter activity in vitro... |
|---|---|
| Item Description: | Gesehen am 19.10.2023 |
| Physical Description: | Online Resource |
| ISSN: | 1099-081X |
| DOI: | 10.1002/bdd.699 |